Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study

Accumulating evidence suggests that the intestinal microbiome may dramatically impact the outcomes of hematopoietic stem cell transplant (HSCT) patients. Providing 16S rRNA based microbiome characterization in a clinically actionable timeframe is currently problematic. Thus, determination of microbial metabolites as surrogates for microbiome composition could offer practical biomarkers.